Corona Virus Second Alzheimer’s treatment showing modest benefits for patients approved by FDA By Posted on January 6, 2023 Share Tweet Share Share Email Comments The agency granted accelerated approval to Leqembi on Friday.Read More Related Items: Share Tweet Share Share Email Click to comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
